Latest News About Qulid

Updated 2026-06-18 16:09

Qulid refers to a project or company with several related items in the news cycle, including clinical programs like QRL-101 and QRL-201 from QurAlis, which are targeted therapies for Kv7 and STATHMIN-2. These programs are distinct from QuidelOrtho diagnostics (QDEL) or other similarly named entities. QurAlis has announced multiple clinical and licensing milestones for its Kv7.2/7.3 and STATHMIN-2 programs.

Sources

QL News | KLSE Screener

Analyse Malaysia stock market better ever. Access everywhere. Available in Google Play Store and App Store!

www.klsescreener.com

Whoops, we’ve hit a bottom.

A high-level overview of ETRACS 2x Leveraged MSCI US Quality Factor TR ETN (QULL). Stay up to date on the latest price, chart, news, analysis, fundamentals, trading and investment tools.

seekingalpha.com

Quidel (QDEL) Stock News & Updates | StockTitan

QuidelOrtho (QDEL) news covers in vitro diagnostics, point-of-care molecular testing, LEX VELO, respiratory demand, earnings, guidance and governance. Latest QDEL news, June 2026.

www.stocktitan.net